News

09.04.2019

Alibion kicks off pre-clinical studies to address Rheumatoid arthritis

26.07.2019

Alibion received 10,000 CHF grant from VentureKick jury after pitching our business plan!

15.10.2019

Alibion selected as 1 of 15 companies chosen for Phase 1 of BaseLaunch